FDA OK's Pharmacia's aseptic system

In December, Peapack, NJ-based Pharmacia Corp. received Food and Drug Administration approval to produce its parenteral drug Caverject on an aseptic filling system that improves sterility assurance before and during vial filling, checkweighing and stoppering processes.

The barrier isolator filling system is supplied by Bosch Packaging Technology NA (Minneapolis, MN). Called the MAFS® (Mini Aseptic Filling System), the equipment was originally installed at Pharmacia’s Kalamazoo, MI, plant in ’97 as part of the company’s Center for Advanced Sterile Technology. This is reportedly FDA’s first approval of a MAFS barrier isolator filling system in the United States.

“This is the next generation of aseptic processing technology,” Arnie DeVisser tells Packaging World. DeVisser, a business unit director at Pharmacia’s Kalamazoo plant, adds, “The technology provides an absolute barrier between product and operator during filling and freeze drying.”

The new line gives Pharmacia an alternative site for manufacture of the product, which is produced at the company’s Kalamazoo facility. The MAFS system includes equipment used to wash, fill, checkweigh, and apply closures within a cleanroom environment. At full-scale production, the line can run at speeds to 400 vials/min.

Caverject, a therapy used for male impotency, is prescribed by medical professionals. Expected to be available this summer, the injectable liquid product is filled in a 10-mL vial within a folding carton. (JB)

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—Packaging World editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce